BDBM510848 N-{(aR)-6-[(5- carbamoyl-2- methyl-1,3-thiazol-4- yl)oxy]spiro[3.3] heptan-2-yl}-1- (difluoromethyl)-6- (2-hydroxy-2- methylpropoxy)-1H- indazole-3- carboxamide::US11078197, Example 25::US11673886, Example 25

SMILES Cc1nc(O[C@H]2C[C@@]3(C[C@@H](C3)NC(=O)c3nn(C(F)F)c4cc(OCC(C)(C)O)ccc34)C2)c(s1)C(N)=O

InChI Key InChIKey=KISPYXVILYDUMA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 510848   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM510848(N-{(aR)-6-[(5- carbamoyl-2- methyl-1,3-thiazol-4- ...)
Affinity DataIC50: 6.40E+3nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2022
Entry Details
Go to US Patent

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM510848(N-{(aR)-6-[(5- carbamoyl-2- methyl-1,3-thiazol-4- ...)
Affinity DataIC50: 6.40nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2023
Entry Details
Go to US Patent